APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi


APEIRON Biologics AG, a company focused on cancer immunotherapy, and Evotec AG announced today that the companies received the first milestone payment from Sanofi under a 3-party alliance signed in August 2015. The milestone payment of 3 million will be split equally between the two biotech companies.



from Biotech News